Yan, Lei
Henegar, Cassidy E.
Marconi, Vincent C.
Gordon, Kirsha S.
Hicks, Charles
Vannappagari, Vani
Justice, Amy C.
Aslan, Mihaela
Article History
Received: 9 August 2024
Accepted: 25 November 2024
First Online: 21 December 2024
Declarations
:
: This work uses data provided by patients and collected by the VA as part of their care and support. The VACS study was approved by the institutional review boards of Yale University (ref Yale: 0309025943) and VA Connecticut Healthcare System (ref VA: AJ0001). It has been granted a waiver of informed consent and is compliant with the Health Insurance Portability and Accountability Act.
: Not applicable.
: ViiV Healthcare contributed to the design of the study, interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Authors who are VA employees participated in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.
: CEH., CH., and VV. are employed by ViiV Healthcare. VCM has received investigator-initiated research grants (to the institution) and consultation fees from Eli Lilly, Bayer, Gilead Sciences, Merck, and ViiV. LY, KG, ACJ, and MA report no conflicts of interest.